Atlas Trials

A Study on How Vedolizumab is Given and the Outcomes for Adults With Inflammatory Bowel Disease (VARIETY-Belgium)

Clinical trial NCT04959851 · COMPLETED

Trial details

NCT number
NCT04959851
Sponsor
Takeda
Status
COMPLETED
Study type
OBSERVATIONAL
Inflammatory Bowel DiseasesColitis, UlcerativeCrohns Disease
Start date
2021-12-02
Primary completion
2024-06-18
Enrollment
185

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.